We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWG icon
5176
NatWest
NWG
$76B
$5K ﹤0.01%
724
+538
+289% +$3.49K
NXPL icon
5177
NextPlat
NXPL
$22.3M
$5K ﹤0.01%
+150
New +$6.77K
OPTN
5178
DELISTED
OptiNose
OPTN
$5K ﹤0.01%
217
+95
+78% +$3.18K
OR icon
5179
OR Royalties Inc
OR
$6.25B
$5K ﹤0.01%
450
-9,943
-96% -$121K
PAAS icon
5180
Pan American Silver
PAAS
$20B
$5K ﹤0.01%
220
-92
-29% -$2.32K
PCY icon
5181
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
$5K ﹤0.01%
181
-245
-58% -$6.48K
PDEX icon
5182
Pro-Dex
PDEX
$214M
$5K ﹤0.01%
199
-1
-0.5% -$24
PFLT icon
5183
PennantPark Floating Rate Capital
PFLT
$730M
$5K ﹤0.01%
+395
New +$5.19K
PROK icon
5184
ProKidney
PROK
$273M
$5K ﹤0.01%
+536
New +$5.3K
PZG icon
5185
Paramount Gold Nevada
PZG
$132M
$5K ﹤0.01%
+7,758
New +$6.11K
QTEC icon
5186
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.92B
$5K ﹤0.01%
28
-8,773
-100% -$1.5M
RDY icon
5187
Dr. Reddy's Laboratories
RDY
$10.2B
$5K ﹤0.01%
405
-445
-52% -$5.61K
SLQD icon
5188
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
$5K ﹤0.01%
+97
New +$4.97K
SLS icon
5189
SELLAS Life Sciences
SLS
$2.58B
$5K ﹤0.01%
894
-2,196
-71% -$16.6K
SSY
5190
DELISTED
SunLink Health Systems
SSY
$5K ﹤0.01%
3,455
+2,406
+229% +$5.3K
SYPR icon
5191
Sypris Solutions
SYPR
$47.4M
$5K ﹤0.01%
+2,084
New +$6.72K
TAOP icon
5192
Taoping
TAOP
$8.12M
$5K ﹤0.01%
9
-3
-25% -$2.5K
TENX icon
5193
Tenax Therapeutics
TENX
$67.4M
$5K ﹤0.01%
+3
New +$6.76K
USMC icon
5194
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.7B
$5K ﹤0.01%
110
-335
-75% -$14.3K
VBNK
5195
VersaBank
VBNK
$658M
$5K ﹤0.01%
393
+33
+9% +$401
VCLT icon
5196
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.74B
$5K ﹤0.01%
+48
New +$5.11K
VPL icon
5197
Vanguard FTSE Pacific ETF
VPL
$8.64B
$5K ﹤0.01%
66
-1
-1% -$80
VTAK icon
5198
Catheter Precision
VTAK
$1.01M
0
WALD icon
5199
Waldencast
WALD
$173M
$5K ﹤0.01%
+506
New +$5K
WATT icon
5200
Energous
WATT
$85.6M
$5K ﹤0.01%
7
-12
-63% -$12.4K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.